Association of Mandatory-Access Prescription Drug Monitoring Programs With Opioid Prescriptions Among Medicare Patients Treated by a Medical or Hematologic Oncologist.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 32379277.
- Also identified by DOI 10.1001/jamaoncol.2020.0804 and PMC identifier 7206528.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines the association between prescription drug monitoring program mandates with and without a cancer exemption and the percent of oncologists’ patients with any opioid prescription covered by Medicare Part D.
Medical subject headings
- Analgesics, Opioid
- Cancer Pain
- Medicare
- Oncologists
- Practice Patterns, Physicians'
- Prescription Drug Monitoring Programs